In Brief
This article was originally published in The Tan Sheet
Executive Summary
Woodcock: FDA maintains NSURE focus; J&J rebrands to regain consumer trust; Symrise AG gains research loan; most allergy sufferers take two or more meds, Teva-funded survey finds; Mead Johnson’s Nutramigen LGG reduces milk allergies; more news In Brief.